SCHEMBL7127023

SCHEMBL7127023

CC(C)(C)C(CCc1ccccc1)(NS(=O)(=O)c1ccc(C(N)=O)cc1)C(N)=O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GHSR Q92847 1/20 0.42
PRMT1 Q99873 1/20 0.42
POLB P06746 1/20 0.41
PLA2G10 O15496 1/20 0.40
PLA2G2A P14555 1/20 0.40
RORC P51449 1/20 0.39
PLAU P00749 1/20 0.39
HPN P05981 1/20 0.39
ALDH1A1 P00352 3/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
TSHR P16473 1/20 0.38
LIMK1 P53667 1/20 0.38
LIMK2 P53671 1/20 0.38
GAA P10253 1/20 0.38
MAPT P10636 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
MMP2 P08253 1/20 0.38
MMP7 P09237 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7124462 0.92 GAA (0.45) GHSRPRMT1ALDH1A1MEN1KMT2A
SCHEMBL7127820 0.89 GHSR (0.43) GHSRPRMT1ALDH1A1MEN1KMT2A
SCHEMBL7121674 0.86 ALDH1A1 (0.54) POLBALDH1A1LIMK2MAPTMMP2
SCHEMBL7125294 0.85 KMT2A (0.58) GHSRPOLBALDH1A1MEN1KMT2A
SCHEMBL7118409 0.85 ALDH1A1 (0.48) ALDH1A1MEN1KMT2AGAAMAPT
SCHEMBL7116603 0.80 PRMT1 (0.43) GHSRPRMT1POLBPLA2G10PLA2G2A
SCHEMBL7126170 0.79 F2 (0.46) ALDH1A1MEN1KMT2AL3MBTL1MMP2
SCHEMBL7116832 0.77 CA9 (0.39) GHSRPOLBMEN1KMT2AMAPT
SCHEMBL7130244 0.76 HTT (0.41) PRMT1POLBPLA2G10PLA2G2APLAU
SCHEMBL7124469 0.75 POLB (0.46) POLBMEN1KMT2ATSHRMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6583318-B2 Carrying out a four component condensation reaction between components consisting of a sulfonamide, an aldehyde or ketone, an isocyanide and a carboxylic acid, and one of such components being attached to a solid support ADVANCED SYNTECH, LLC 2003-06-24 US disclosed
US-20030013910-A1 Method for synthesis of alpha-sulfonamido amide, carboxylic acid and hydroxamic acid derivatives ADVANCED SYNTECH LLC 2003-01-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030013910-A1 Method for synthesis of alpha-sulfonamido amide, carboxylic acid and hydroxamic acid derivatives ASPH, COASY, HAAO GHSR 2089/4885PRMT1 2833/4885POLB 1804/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.